Communicating the benefits, harms and risks of medical interventions: In journals; to patients and public

International Journal of Surgery

Volumn 7, Issue 1, 2009, Pages 3-6

  Thornton, Hazel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOCTOR PATIENT RELATION; EDITORIAL; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL PRACTICE; PATIENT PARTICIPATION; PRIORITY JOURNAL;

COMMUNICATION; HUMANS; PATIENT EDUCATION AS TOPIC; PERIODICALS AS TOPIC; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 61449243613     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2008.11.005     Document Type: Editorial

References (37)

1. Gigerenzer G., and Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 327 (2003) 741-744
2. Agha R., Cooper D., and Muir G. The reporting quality of randomized controlled trials in surgery: a systematic review. Int J Surg 5 6 (2007) 413-422
3. Thornton H. Reporting quality-the weakest link?. Int J Surg 5 (2007) 374-375
4. Glasziou P., Burls A., and Gilbert R. Evidence based medicine and the medical curriculum. BMJ 337 (2008) 704-705
5. Turney J. Understanding and engagement. The changing face of science and society. Wellcome Trust. Available at:. [accessed 30.10.08]
6. General Medical Council. Consent: patients and doctors making decisions together. London: General Medical Council; 2 June 2008.
7. Parmar M.S. We do things because. Br Med J (March 1st 2004) Rapid Response
8. Jorgensen K.J., Klahn A., and Goetzsche P. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med 5 (2007) 12 10.1186/1741-7015-5-12
9. Essali MA. Foreword to the Arabic translation, by Adib Essali (email: ), of Testing Treatments: Better Research for Better Healthcare (Evans, Thornton and Chalmers) 2007. Arabic foreword translated into English by Hazim Timimi (email: htimimi@lindalliance.org), with help from Adib Essali, October 2007 (Last para. Page 1).
10. Dixon-Woods M., Agarwal S., Jones D., Young B., and Sutton A. Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy 10 1 (2005 Jan) 45-53
11. Sakel M. Does this drug work? The untold part of the story. Rapid response 2nd November 2008 to Christakis NA. Does this work for you?. BMJ 337 (30th October 2008) a2281. Available at: [accessed 15.12.08]
12. McCartney M. Reality check. Financial Times Magazine (27th/28th September 2008)
13. Developing methods of communicating benefits and harms of medical interventions through journals. Academy of Medical Sciences Workshop. 5th September 2008, London.
14. Ioannidis J.P.A., Evans S., Goetzsche P.C., O'Neill R.T., Altman D.G., Schulz K., et al., for the CONSORT Group. Better reporting of hams in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141 10 (2004) 781-788
15. Messai R. A breast cancer terminology for lay people. Speaker proffered paper Friday 24th March 2006. In: Europa Donna workshop: 'should advocates be involved in the design of clinical trials?' 5th European Breast Cancer Conference. Nice, France.
16. Aronson J. When I use a word. Balancing benefits and harms in health care. BMJ 329 (2004) 30
17. Herxheimer A. Benefit, risk and harm. Australian Prescriber 24 1 (2001) 18
18. Smith R. Editor's choice. Think harm always. BMJ (2004) 329
19. Balancing benefits and harms in health care. BMJ 7456 (3 July 2004)
20. Communicating risks: illusion or truth?. BMJ 7417 (27th September 2003)
21. Thornton H. Report on EQUATOR network launch meeting 26th June 2008 "achieving transparency in reporting health research". Int J Surg 6 6 (2008) 428-431
22. General Medical Council. Seeking patients' consent: the ethical considerations (1998), GMC, London
23. Evans I., Thornton H., and Chalmers I. Testing treatments: better research for better healthcare (2006), British Library. http://www.jameslindlibrary.org Available free of charge on the James Lind Library website under a Creative Commons Attribution 3.0 Unported Licence
24. Craig P., Dieppe P., MacIntyre S., Mitchie S., Nazareth I., and Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 357 (2008) a1655 10.1136/bmj/1655
25. Cochrane A.L., and Holland W.W. Validation of screening procedures. Br Med Bull 27 (1971) 3-8
26. Berry D, in Ref. [11] above.
27. Goetzsche P.C., and Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev (2006) 10.1002/14651858.CD001877.pub.2 Issue 4, Art. No.: CD001877
28. NHS Cancer Screening Programme. Breast screening: the facts. Available at: (2007).
29. Breast cancer slogan reality check: "1 in 9"-if you're 90! Misuse of "1 in 9" slogan defended by two leading organizations' directors on grounds of consistency and popularity. International Journal of Surgery, 2008;6:426-7. Online 14 October 2008. doi: 10.1016/j.ijsu.2008.10.002.
30. In Ref. [6]. Evans I., Thornton H., and Chlamers I. Testing treatments: better research for better healthcare (2006), British Library Page 20: adapted from Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Paper No. 34. Geneva: World Health Organisation. 1968
31. Thornton H. Patients' understanding of risk. Enabling understanding must not lead to manipulation. BMJ 327 (2003) 693-694
32. Entwistle V., Carter S.M., Trevena L., Flitcroft K., Irwig L., McCaffrey K., et al. Communicating about screening. BMJ 337 (2008) 789-791
33. Tversky A., and Kahneman D. The framing of decisions and the psychology of choice. Science 211 (1981) 453-458
34. McNeil BJ, Pauker SG, Tversky A. On the Framing of Medical Decisions. In: Bell DE, Raiffa H, Tversky A, editors. Decision Making: Descriptive, Normative, and Prescriptive Interactions. Cambridge, MA: Cambridge University Press; 1988;26:562-8.
35. Gigerenzer G. Reckoning with risk. Learning to live with uncertainty (2002), Penguin Books, London pp. 45
36. Moore R.A., Derry S., McQuay H., and Paling J. What do we know about communicating risk? A brief review and suggestions for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs. Arthritis Res Ther 10 (2008) R20 10.1186/ar2373
37. Edwards A.E. Communicating risks. Means that patients too have to learn to live with uncertainty. BMJ 327 (2003) 691-692